Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
18
currently held
Exits tracked
15
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin28 companies matching
Agomab Therapeutics
Boehringer Ingelheim Venture Fund
BelgiumSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2019
Hold
7yr
Owners
3
Exit
2026
to Nasdaq (IPO)
Paleo
Planet A Ventures Fund I
BelgiumSector
Biotech
InvestorPlanet A Ventures
Entry
2023
Hold
3yr
Owners
2
EsoBiotec
Invivo Ventures
BelgiumSector
Biotech
InvestorInvivo Partners
Entry
2023
Hold
2yr
Exit
2025
to AstraZeneca
ABOLERIS PHARMA
Criteria Bio Ventures
BelgiumSector
Biotech
InvestorCaixa Capital Risc
Entry
2020
Hold
4yr
Owners
2
S-Biomedic
Oscar & Paul Venture Capital Fund I
BelgiumSector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2018
Hold
4yr
Exit
2022
to Beiersdorf AG
Xpress Biologics
MED III
BelgiumSector
Biotech
InvestorARCHIMED
Entry
2021
Hold
1yr
Exit
2022
to Polyplus (ARCHIMED portfolio company at the time, intra-portfolio)
Ablynx NV
Sofinnova Capital VI
BelgiumSector
Biotech
InvestorSofinnova Partners
Entry
2008
Hold
10yr
Exit
2018
to Sanofi
TiGenix
Ysios BioFund I
BelgiumSector
Biotech
InvestorYsios Capital Partners
Entry
2007
Hold
11yr
Exit
2018
to Takeda
Complix
BioDiscovery 4
BelgiumSector
Biotech
InvestorAndera Partners
Entry
2013
Hold
4yr
Exit
2017
to Merck KGaA
Covagen
BioDiscovery 3
BelgiumSector
Biotech
InvestorAndera Partners
Entry
2010
Hold
4yr
Owners
2
Exit
2014
to Johnson & Johnson
Oncoethix
BioDiscovery 4
BelgiumSector
Biotech
InvestorAndera Partners
Entry
2013
Hold
1yr
Exit
2014
to Merck & Co.
Movetis
Sofinnova Capital VI
BelgiumSector
Biotech
InvestorSofinnova Partners
Entry
2008
Hold
2yr
Exit
2010
to Shire
Complement Therapeutics
Panakes Fund Purple
BelgiumSector
Biotech
InvestorPanakes Partners SGR
Entry
2023
Hold
3yr
Owners
3
Biotalys
Gimv Portfolio
BelgiumSector
Biotech
InvestorGimv
Entry
2019
Hold
7yr
Owners
2
Animab
AVF Fund
BelgiumSector
Biotech
InvestorSeventure Partners
Entry
2020
Hold
6yr
Botalys
ALIAD
BelgiumSector
Biotech
InvestorAliad Venture Capital
Entry
2022
Hold
4yr
Confo Therapeutics
Wellington Partners Life Sciences
BelgiumSector
Biotech
InvestorWellington Partners
Entry
2019
Hold
7yr
Corpowell (Vecollal)
Health for Life Capital
BelgiumSector
Biotech
InvestorSeventure Partners
Entry
2021
Hold
5yr
Montis Biosciences
ALSA Ventures European Biotechnology Fund
BelgiumSector
Biotech
InvestorALSA Ventures
Entry
2020
Hold
6yr
Obulytix
Boehringer Ingelheim Venture Fund
BelgiumSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2023
Hold
3yr
The Akkermansia...
Health for Life Capital
BelgiumSector
Biotech
InvestorSeventure Partners
Entry
2020
Hold
6yr
Exciva
LifeArc Ventures
BelgiumSector
Biotech
InvestorLifeArc
Entry
2019
Hold
7yr
Owners
4
Kivu Bioscience
Novo Holdings Venture Investments
BelgiumSector
Biotech
InvestorNovo Holdings
Entry
2025
Hold
1yr
Owners
3
Azalea Vision
Elaia Alpha II
BelgiumSector
Biotech
InvestorElaia Partners
Entry
2021
Hold
5yr
Owners
2
Rewind Therapeutics
Sunstone Life Science Ventures V
BelgiumSector
Biotech
InvestorSunstone Life Science Ventures
Entry
2017
Hold
9yr
Owners
2
AmphiStar
European Circular Bioeconomy Fund
BelgiumSector
Biotech
InvestorECBF Management GmbH
Entry
2024
Hold
2yr
Univercells
AFB Fund II
BelgiumSector
Biotech
InvestorAdBio Partners
Entry
2022
Hold
4yr
Virovet
Health for Life Capital II
BelgiumSector
Biotech
InvestorSeventure Partners
Entry
2023
Hold
3yr